Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

NCT04072237 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A
Hemophilia B
Hemophilia A With Inhibitor
Hemophilia B With Inhibitor
Hemophilia A Without Inhibitor
Hemophilia B Without Inhibitor

Interventions

BIOLOGICAL: MarzAA (marzeptacog alfa [activated])

Sponsor

Catalyst Biosciences